Published 
On September 1st and 2nd, 2024, SiCORE-M and SiCORE-Allergy jointly hosted the Scientific Advisory Board (SAB) ‘s onsite meeting at the Siriraj Medical Research Building (SiMR), Faculty of Medicine, Siriraj Hospital. The event began with a guided laboratory visit and a comprehensive discussion of the current Allergy projects.
The meeting was graced by the presence of Prof. Apichat Asavamongkolkul, Dean of the Faculty of Medicine, Siriraj Hospital, who extended a warm welcome to the visiting renowned experts, Prof. Rudolf Valenta from the Medical University of Vienna and Prof. Stephen Durham from Imperial College London. Their guidance and special lectures added immense value to the discussions.
Assoc. Prof. Pongsakorn Tantilipikorn, Director of SiCORE-Allergy, along with Assoc. Prof. Nitaya Indrawattana, Dr. Dichapong Kanjanawasee, and Dr. Nathachit Limjunyawong presented the progress and challenges in developing intranasal allergen preparations. The discussions focused on the strategic transition from cockroach to house dust mite intranasal immunotherapy based on unmet needs and initial research findings. As the team prepares for the first human trials under Thai FDA product registration, the SAB’s full approval for the shift was a significant validation, noting the significant prevalence and impact of house dust mite allergies in Thailand. Additionally, the meeting highlighted the molecular analysis of cockroach allergens and their cross-reactivity with house dust mites, marking important directions for future research.
